Lysophosphatidic Acid Receptor 1 抗体

Harper, Brochu-Gaudreau, Saucier, Dubois: "Hypoxia Downregulates LPP3 and Promotes the Spatial Segregation of ATX and LPP1 During Cancer Cell Invasion." in: Cancers, Vol. 11, Issue 9, (2019) (PubMed).

Chen, Zhang, Deng, Liu, Yang, Wu, Yu: "Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI." in: Biochemical and biophysical research communications, Vol. 491, Issue 3, pp. 587-594, (2017) (PubMed).

Wu, Yuan, Wang, Wei, Xu: "Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X3 receptor-mediated bone cancer pain in rats." in: Molecular pain, Vol. 12, (2016) (PubMed).

Sokolov, Eheim, Ahrens, Walling, Swet, McMillan, Simo, Thompson, Sindram, McKillop: "Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma." in: The Journal of surgical research, Vol. 180, Issue 1, pp. 104-13, (2013) (PubMed).

Arriazu, Durán, Pozuelo, Santamaria: "Expression of lysophosphatidic acid receptor 1 and relation with cell proliferation, apoptosis, and angiogenesis on preneoplastic changes induced by cadmium chloride in the rat ventral prostate." in: PLoS ONE, Vol. 8, Issue 2, pp. e57742, (2013) (PubMed).

Wei, Johansson, Chen, Song, Tolman, Li, Hurd, Patidar, Wen, Badgett, Cheuk, Marshall, Steeg, Vaqué Díez, Yu, Gutkind, Khan: "Massively parallel sequencing reveals an accumulation of de novo mutations and an activating mutation of LPAR1 in a patient with metastatic neuroblastoma." in: PLoS ONE, Vol. 8, Issue 10, pp. e77731, (2013) (PubMed).

Park, Kazlauskas: "Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA)." in: Bioscience reports, Vol. 32, Issue 4, pp. 393-400, (2012) (PubMed).

Ward, Lake, Yin, Heger, Raffeld, Goldsmith, Merino, Kelly: "LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells." in: Cancer research, Vol. 71, Issue 23, pp. 7301-11, (2011) (PubMed).

Horak, Mendoza, Vega-Valle, Albaugh, Graff-Cherry, McDermott, Hua, Merino, Steinberg, Khanna, Steeg: "Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2." in: Cancer research, Vol. 67, Issue 24, pp. 11751-9, (2007) (PubMed).

Boucharaba, Serre, Guglielmi, Bordet, Clézardin, Peyruchaud: "The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 25, pp. 9643-8, (2006) (PubMed).